Women were less than half of the people tested for almost all of these common medicines.

NCT00699192

Safety, Tolerability, and Efficacy of Once Daily Amlodipine/Valsartan 5/80 as Compared to Amlodipine/Valsartan 5/40 or to Amlodipine 5 mg Monotherapy in Patients 65 Years of Age and Older With Essential Hypertension

See it on ClinicalTrials.gov ↗

819 people

432 womenmiddle line = equal numbers387 men
Phase
PHASE3
Paid for by
Novartis Pharmaceuticals
Finished
2009-05
Health conditions
Hypertension
Who could join
Anyone
Ages
65 Years – no maximum
Average age
mean 71.6 years
Age 65+
Not reported
Weight (BMI)
Not reported
Pregnancy recorded
Not reported
Menopause recorded
Not reported
Results shown by sex
Not split by sex
Race
Not reported

Women left out

  • Only women past menopause

    Women who could still get pregnant were turned away.

    “Female patients had to be post-menopausal for at least one year.”
  • No kidney or liver problems

    Women with kidney or liver problems were turned away.

    “Significant hepatic disease, as demonstrated by any one of the following: aspartate aminotransferase (AST) or alanine aminotransferase (ALT) values greater than two times the upper limit of normal at Visit 1, a history of hepatic encephalop…”
  • No heart disease

    Women with heart disease, heart rhythm problems or a past heart attack were turned away.

    “Significant history of coronary artery disease (CAD) such as any history of myocardial infarction (MI), angina pectoris, and all types of revascularization procedures.”
  • No diabetes

    Women with diabetes were turned away.

    “All patients with Type 1 diabetes mellitus and those patients with Type 2 diabetes mellitus who, in the opinion of the investigator, were not well controlled. Patients who needed oral anti-diabetic medication to adequately control their Typ…”
  • No cancer

    Women with current or past cancer were turned away.

    “Known moderate or malignant retinopathy. Moderate was defined as retinal signs of hemorrhage, microaneurysm, cotton-wool spot, hard exudates, or a combination thereof; malignant defined as signs of moderate retinopathy plus swelling of the…”

Study titles and rules are shown in their original English.